AUA 2025: Efficacy and Safety of Padeliporfin Vascular Targeted Photodynamic Therapy for Treatment of Low-Grade Upper Tract Urothelial Cancer: ENLIGHTED Phase 3 Study
AUA 2025 phase 3 ENLIGHTED study, padeliporfin vascular targeted photodynamic (VTP) therapy for treatment of low-grade upper tract urothelial cancer.